Abiopharma

Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026

BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry

Lillys orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial

New Form DEF 14A - FibroBiologics, Inc. Filed: 2025-12-18 AccNo: 0001193125-25-323667 Size: 876 KB

Pink Limited symbol attribute type Security_Name was changed. Previous value: HEINEKEN CDR BMO HDGD S. New value: CLEVER LEAVES HLDGS WTS.

(99% Neutral) Incannex Healthcare Inc. (IXHL) Provides Business Update

New Form DEFA14A - Incannex Healthcare Inc. Filed: 2025-12-18 AccNo: 0001213900-25-123039 Size: 14 KB

New Form EFFECT - Fortress Biotech, Inc. Filed: 2025-12-17 AccNo: 9999999995-25-003815 Size: 1 KB

New Form EFFECT - ADIAL PHARMACEUTICALS, INC. Filed: 2025-12-17 AccNo: 9999999995-25-003812 Size: 1 KB

New Form EFFECT - Biodexa Pharmaceuticals Plc Filed: 2025-12-17 AccNo: 9999999995-25-003807 Size: 1 KB

GSK plc (GLAXF) Files Form 6-K

Takeda Pharmaceutical Co., Ltd. (TKPHF) Files Form 6-K

(99% Neutral) BEONE MEDICINES LTD. (BGNE) Announces New Board Appointment

Busch Richard 🟢 acquired 175.0K shares of American Bitcoin Corp. (ABTC) at $1.66 Transaction Date: Dec 16, 2025 | Filing ID: 323509

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy